Future Forward Insights

Each of us at Nolan Heimann has an affinity for new frontiers, from immersive entertainment and influencer brands to blockchain, DAO’s, and the metaverse(s), we are attorneys with deep knowledge that provide detailed expertise in executing novel aspects of our clients’ strategies. Protecting IP, while planning for its future growth and monetization, is at the heart of what we do.

These insights are offered as an expression of our commitment to helping all creators and business makers structure their ventures on solid, authentic foundations to enable growth and transformation. Keep up-to-date with our monthly newsletter. Subscribe at the bottom of our site.

Patenting for Inventors Ep. 158: The Pre-Patent Power Play: Can I License My Invention While It’s Still Patent Pending?

Patenting for Inventors Ep. 158: The Pre-Patent Power Play: Can I License My Invention While It’s Still Patent Pending?

Wondering whether you can license your invention before the patent is granted? In this episode, patent attorney Adam Diament unpacks the practical strategies—and legal risks—of licensing while your patent is still pending. From early cash to future royalties, here’s what’s at stake.

Read More
Patenting for Inventors Ep. 154: Can AI be an Inventor? Guidance from the Patent Office

Patenting for Inventors Ep. 154: Can AI be an Inventor? Guidance from the Patent Office

Can AI be named as an inventor on a patent? Not yet. In this episode, patent attorney Adam Diament breaks down the latest guidance from the USPTO on AI-assisted inventions. Learn what counts as a “significant human contribution,” how AI can (and can’t) support the patent process, and why proper inventorship still matters in the age of machine collaboration.

Read More
Patenting for Inventors Ep. 150: What is Obviousness? A “Reasonable Expectation of Success” or “Predictable Results”?

Patenting for Inventors Ep. 150: What is Obviousness? A “Reasonable Expectation of Success” or “Predictable Results”?

Obviousness is a crucial factor in patent law, particularly in biotech. In this episode, host Adam Diament explores Vanda Pharmaceuticals v. Teva Pharmaceuticals, a case that established the reasonable expectation of success standard for determining obviousness.

The ruling invalidated Vanda’s patent for Hetlioz, and when the Supreme Court declined to review the case, the Federal Circuit’s decision became law. What does this mean for future biotech patents? Tune in as Diament breaks down the impact of this ruling and why obviousness remains one of the most challenging issues in patent law.

Read More
Patenting for Inventors Ep. 139: How Do I Know if My Design is Patently Obvious?

Patenting for Inventors Ep. 139: How Do I Know if My Design is Patently Obvious?

The law may be changing soon on how to determine whether your new design is patentable. In this podcast episode, learn the about the controversy behind the patentability standard for design patent obviousness.

Read More
META This! Ep.5: Does Your Employer Own Your Invention? Take the Quiz

META This! Ep.5: Does Your Employer Own Your Invention? Take the Quiz

Adam Diament, our patent attorney, gets into it with Ted Nguyen, who specializes in entertainment law; it’s all about patent prosecution, utility patents, who owns what, and for how long.

Read More